Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Safello lists Litecoin and Bitcoin Cash

Stockholm, 8 May 2024 | Safello, the leading cryptocurrency exchange in the Nordics, is adding two more cryptocurrencies to its portfolio: Litecoin (LTC) and Bitcoin Cash (BCH). In selecting these currencies, Safello has followed strict guidelines within the framework of the company's product governance, considering factors such as liquidity, traceability on the blockchain, and for how long the product has been available in the market. The cryptocurrencies are available for trading from today via safello.com and in Safello’s mobile application for iOS and Android. Safello now

Epiroc awards recognize outstanding customer collaboration and innovation

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, is recognizing with three annual awards exceptional collaboration with a customer on battery-electric vehicles, a revolutionary automatic bit changer, and an internal program fostering innovation.“All the award winners represent the outstanding innovative mindset that is a key to Epiroc’s and our customers’ success,” says Helena Hedblom, Epiroc’s President and CEO. “Throughout the organization, we keep focusing on providing our customers with the best solutions to boost

Interim Report Q1 – January – March, 2024 Redsense Medical AB (publ.)

January – March 2024 · Net sales amounted to kSEK 1,711 (6,824)   · Operating loss, EBIT amounted to kSEK 2,656 (104).   · Result after tax amounted to kSEK -2,640 (413).   · Earnings per share were SEK -0.19 (0.03).   Significant events during the period · On January 8, Eva Walde was appointed new Chairman of the Board at Redsense Medical AB (publ.)   · On January 9, Redsense announced a change in the Nomination Committee for the 2024 Annual General Meeting.   · On February 6, the largest owner Seventh Sense Adventures Holdings AB

LEAX Interim Financial Report Q1 2024

Continued focus on adaptation, quality and growthThe first quarter in summary •                           Net Sales decreased to SEK 560.8 million (588.6) •                           Operating profit decreased to SEK 6.4 million (19.8) •                           Earnings before tax (EBT) decreased to SEK -0.2 million (13.7) •                           Net income for the period decreased to SEK -1.1 million (11.3) •                           Cash flow from operating activities amounted to SEK 26.1 million (53.7) Comments from the Group President and CEO, Roger Berggren;

Everfuel presents first quarter 2024 results on 15 May

Herning, 8 May 2024 – Everfuel A/S will release first quarter 2024 results on Wednesday, 15 May at 07:00 CET. CEO Jacob Krogsgaard and CFO Jesper Ejlersen will present the company's results at 09:00 CEST and invite investors, analysts, and media to join the live webcast presentation. The presentation is expected to last up to one hour, including Q&A, and can be followed via live webcast. Webcast: Join the results webcast on Teams via the following link: Q1 2024 results presentation  

WntResearch’s CEO to BioStock: “If the effect is confirmed, there are good opportunities for licensing agreements next year”

In the Q1 report, Per Norlén writes his first CEO statement for WntResearch since taking office in March. The company’s focus right now is on the NeoFox study where recruitment is in full swing. – We will put most of our focus on patient recruitment and business development in the near future, says Per in a comment to BioStock.Read the full article at biostock.se : https://www.biostock.se/en/2024/05/wntresearchs-ceo-if-the-effect-is-confirmed-there-are-good-opportunities-for-licensing-agreements-next-year/ This is a press release from BioStock -

Relais Group Plc launches a Share Buy-Back Program

Relais Group Plc Stock Exchange Release 8 May 2024 at 9:15 a.m. EEST  The Board of Directors of Relais Group Plc (“Relais Group” or the “Company”) has today on 8 May 2024, decided to launch a share buy-back program concerning Relais Group's own shares based on the authorization to repurchase own shares granted by the Annual General Meeting held on 10 April 2024. The shares to be acquired under the program will be repurchased from the market, which means that the repurchases will be carried out otherwise than in proportion to the existing shareholdings of shareholders (directed

Relais Group Plc appoints Lago Kapital as liquidity provider

Relais Group Plc Stock Exchange Release 8 May 2024 at 9:15 a.m. EEST  Relais Group Plc has entered into a Liquidity Providing (LP) agreement with Lago Kapital Ltd within the framework of Nasdaq Helsinki rules for liquidity provision. According to the agreement, Lago Kapital Ltd will quote bids and offers for Relais Group Plc’s share in such a way that the spread of the bid and offer prices is a maximum of 4 per cent calculated on the bid price. The quotes on bid and offer must be at least EUR 3,000 worth of shares. Lago Kapital Ltd shall quote bids and offers for Relais Group Plc’

The Board of Directors of Relais Group Plc decided on new stock option plans and change to the terms of the 2021 long-term incentive plan

Relais Group Plc Stock Exchange Release 8 May 2024 at 9:15 EEST New Stock Option Plans 2024A and 2024B The Board of Directors of Relais Group Plc has decided to launch two new stock option plans 2024A and 2024B for key employees. The company has a weighty financial reason for the issue of stock options, since the stock options are intended to form part of the Group's incentive and commitment program for the key employees. The purpose of the stock options is to encourage the key employees to work on a long-term basis in order to increase shareholder value. In addition, the stock

Oneflow announces a significant expansion of its strategy with a new AI-powered platform

Press release8 May 2024 Oneflow launches Oneflow AI , an AI-powered platform to help businesses write, review and analyze contracts 10x faster and at scale. “The future of contracts is not just digital—it's augmented by AI,” says Anders Hamnes, CEO and Founder of Oneflow as the company introduces Oneflow AI, a platform of pre-trained AI packages to help businesses write, review and analyze contracts 10x faster and at scale. Oneflow, a SaaS company trading on Stockholm’s Nasdaq First North Premier Growth Market, builds a contract automation platform to

TORM plc Q1 2024 results, dividend distribution, and financial outlook 2024

"Our strong performance extended into the first quarter of 2024, supported by favorable market conditions and the timely delivery of vessels acquired in 2023,” says Jacob Meldgaard, adding: ”Sustained geopolitical tensions continue to contribute to TORM’s strong results.” Financial results In the first quarter of 2024, TORM grew time charter equivalent earnings (TCE) to USD 330.7m (2023, same period: USD 265.0m) and realized an EBITDA of USD 265.8 m (2023, same period: USD 198.5m) and a net profit of USD 209.2m (2023, same period: USD 153.6m). Again, in this quarter the product

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the dividend for April 2024

Oslo, Norway, May 8, 2024 Commercial update: In April 2024, the Company achieved average time charter equivalent rate (“TCE")* of approximately US$31,300 per day, gross, for the Company’s vessels trading on index-linked time charter including average daily scrubber benefits of approximately US$3,600 per day. The Company had 180 operational days in April 2024. The Baltic 5TC Capesize Index averaged US$20,036 during April 2024. *Average time charter equivalent rate, gross, (“TCE") when used by the Company, means time charter revenues and voyage charter revenues excluding address

ContextVision AB: Q1 interim report 2024 - Building for the future and leading innovation

Q1 Highlights ·Participation in the European Congress of Radiology in Vienna meeting new potential customers and following up on previous discussions with potential customers. ·Celebrating 25 years of partnership with a customer, underscoring our commitment to long-lasting relationships and techological leadership. ·Rebuilding of the internal product development structure to enable faster and more frequent product releases in the future. ·Continued strategic investments in Point of Care Ultrasound (POCUS) with the recruitment of a program lead in the USA. Q1

2020 Bulkers Ltd. (2020) - Results for the first quarter of 2024

Oslo, Norway, May 8, 2024 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three months ended March 31, 2024. Key events during the first quarter of 2024 · The Company reported net profit of US$28.5 million and EBITDA of US$34.4 million for the first quarter of 2024. The results include a US$20.5 million gain from the sale of Bulk Shanghai which was delivered to the buyer on March 20, 2024. · Achieved average time charter equivalent earnings of approximately US$30,000 per day, gross. · The Company

CONCENTRIC INTERIM REPORT JANUARY – MARCH 2024

FIRST QUARTER 2024 · Net sales: MSEK 1,003 (1,127) – down –11% year-on-year with no major foreign exchange movements. Compared to Q4 2023 sales are up +9% in constant currency. · Operating income: Operating income was MSEK 137 (181) generating an Operating margin of 13.7% (16.1), up +1.6% from Operating margin before items affecting comparability of 12.1% reported in Q4 2023. · Net income for the period: MSEK 100 (121); basic EPS of SEK 2.69 (3.18). · Cash flow from operating activities: Cash flow from operating activities was MSEK 43 (89) with a profit to cash conversion

Swiss startup Yuon Control AG secures funding to boost needed innovation in heating sector

Kiilto Ventures has invested in Burgdorf-based Cleantech startup Yuon to help accelerate market adoption of their predictive, self-learning heating control system designed to optimize heating networks. Compared to traditional heating control systems, Yuon can help reduce energy consumption and CO2 emissions by up to 25%.Decarbonising heating – A climate imperative Heating is the main use of energy by households in the European Union (EU), accounting for 64.4% of final energy consumption in the residential sector in 2021. As the transition to sustainable heating solutions continues and is

Orthex will publish its Interim Report for January−March 2024 on Wednesday, 15 May 2024

Orthex Corporation, Press release, 8 May 2024 at 9.00 a.m. EESTOrthex will publish its Interim Report for the period January−March 2024 on Wednesday, 15 May 2024 at around 9.00 a.m. EEST. Following the publication, the report will be available in pdf-format on the corporate website at https://investors.orthexgroup.com/.Orthex’s CEO Alexander Rosenlew, CFO Saara Mäkelä and CMSO Hanna Kukkonen will present the report on the same day at 11.00 a.m. EEST in a webcast. The webcast can be joined through this link . The result presentation will be held in

Remedy Entertainment Plc: Changes in Remedy’s Core Management Team

Remedy Entertainment Plc      Stock Exchange Release      May 8, 2024, at 9.00 a.m. EEST Changes in Remedy’s Core Management Team Terhi Kauppi, the Chief Financial Officer of Remedy Entertainment Plc (“Remedy”), has resigned to pursue new career opportunities outside of the company and will leave Remedy on June 30, 2024. The company has already started the search for Kauppi’s successor. Kauppi's responsibilities will be shared by Remedy’s finance team until the new Chief Financial Officer begins in the role. “Terhi Kauppi joined Remedy in 2018 and has had an important role in

Securitas AB Interim Report Q1 2024 January–March

January–March 2024 · Total sales MSEK 39 260 (37 751) · Organic sales growth 7 percent (12) · Real sales growth within technology and solutions 7 percent (77) · Operating income before amortization MSEK 2 357 (2 180) · Operating margin 6.0 percent (5.8) · Earnings per share SEK 1.84 (1.66) · Earnings per share before IAC, SEK 2.12 (2.03) · Net debt/EBITDA ratio 2.9 (3.3*) · Cash flow from operating activities –15 percent (9) *  The comparative is adjusted and includes STANLEY Security’s 12 months adjusted estimated EBITDA. Comments from the President and

YIT is the ideal construction industry employer for engineering students for the sixth consecutive year

YIT Corporation Press Release 8 May 2024 at 9:00 a.m.Engineering students have ranked YIT as the most ideal construction industry employer in Universum’s Student Survey for the sixth consecutive time. In the ranking list of ideal engineering employers, YIT achieved seventh place. This year, YIT aims to offer summer jobs or trainee positions to approximately 350 young people. Engineering students ranked YIT as the most ideal construction industry employer in Universum’s Student Survey 2024, for the sixth consecutive year. A total of 3,125 engineering students responded to the survey. YIT

Orexo Q1 2024 Interim Report

Starting 2024 with a positive EBITDAQ1 2024 highlights›     Total net revenues of SEK 139.3 m (158.8)›     EBITDA of SEK 15.9 m (-41.1) ›     Net earnings of SEK -8.9 m (-63.9)›     US Commercial segment net revenues of SEK 129.3 m (140.3), in local currency USD 12.4 m (13.5)›     Cash flow from operating activities of SEK -18.9 m (-61.6), cash and invested funds of SEK 198.0 m (278.9)›     Earnings per share before and after dilution amounted to SEK -0.26 (-1.86)›     MODIA® and Vorvida® were reimbursed within the US Veterans Affairs Federal Supply Schedule as of January 1,

ContextVision publishes Webcast for Q1 2024

Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q1 2024 along the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVisionContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market

There are no items matching the current filter
There are no more items matching the current filter
Back to top